MedPath

LISA vs INSURE in Extremely Low Birth Weight Infants. A Manikin Study

Not Applicable
Completed
Conditions
Respiratory Distress Syndrome
Preterm Birth
Surfactant Deficiency Syndrome Neonatal
Interventions
Procedure: LISA approach
Procedure: Insure approach
Registration Number
NCT04944108
Lead Sponsor
University Hospital Padova
Brief Summary

This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA vs. INSURE in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the total time of device positioning. The secondary outcomes will be the success of the first and the participant's satisfaction.

Detailed Description

Background: Although LISA offers some advantages in ventilation procedure and neonatal outcomes over INSURE, the use of a catheter during LISA may have some drawbacks such as the prolonged duration of the laryngoscopy needed to insert the device. This is likely to aggravate the invasiveness of the procedure, resulting in stressful consequences such as bradycardia, hypoxia and hemodynamic changes.

Objectives: i) time of device positioning, ii) success of the procedure of positioning the device, iii) participant's satisfaction.

Methods: This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA vs. INSURE in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the total time of device positioning. The secondary outcomes will be the success of the first and the participant's satisfaction.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Level III NICU consultants and residents will be eligible to participate in the study.
Read More
Exclusion Criteria
  • There are no exclusion criteria for this study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Surfactant administration with less invasive surfactant administration (LISA) approachLISA approachParticipants will be randomized to administer surfactant in a preterm manikin by using the LISA approach (thin catheter)
Surfactant administration with intubation (INSURE) approachInsure approachParticipants will be randomized to administer surfactant in a preterm manikin by using the INSURE approach (tracheal tube)
Primary Outcome Measures
NameTimeMethod
Time of device positioning10 minutes

Time needed for the correct positioning of the device into the trachea (thin catheter or tracheal tube). In case of failure, total time will be the sum of time of all attempts.

Secondary Outcome Measures
NameTimeMethod
Success of the procedure at the first attempt1 minute

It refers at the success of the device positioning during the first attempt

Participant's satisfaction5 minutes

At the end of the procedure, all participants will be required to fill a 5-item questionnaire aimed to assess their perception on the procedure (Likert scale)

Correct depth of the device in the trachea10 minutes

It refers to reaching the correct depth in the trachea as assessed by the external observer using a laryngoscope

Number of attempts to insert the device in the trachea10 minutes

It refers to the number of attempts to insert the device in the trachea

Trial Locations

Locations (2)

University Hospital of Padova

🇮🇹

Padova, Italy

Poliambulanza Breacia

🇮🇹

Brescia, Italy

© Copyright 2025. All Rights Reserved by MedPath